Skip to content

Validation of Heart Rate Recovery as a Peri-operative Risk Measure

Validation of Heart Rate Recovery as a Peri-operative Risk Measure (VERVE)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05561608
Acronym
VERVE
Enrollment
84
Registered
2022-09-30
Start date
2022-02-10
Completion date
2024-08-01
Last updated
2025-07-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peri-operative Injury

Keywords

Heart rate recovery, Submaximal exercise testing, Post-operative myocardial injury, Validation

Brief summary

Is heart rate recovery after submaximal exercise (i.e. not to exhaustion) a valid risk measure for post-operative outcomes?

Detailed description

There are approximately 1.5 million major operations carried out in the NHS every year. As the population ages, and surgical technique becomes more advanced, more patients are undergoing operations which carry a high risk of complications. Currently, doctors predict this risk by asking patients about medical problems and their level of physical fitness. If an operation is very high risk, a patient may undergo cardiopulmonary exercise testing (CPET) where the patient rides an exercise bike to maximum effort (exhaustion) whilst their heart and lung function is measured. This gives the doctor specific numbers which can be discussed with the patient about the risk of complications after surgery. However, CPET is expensive and not all patients are able to do it, for example due to joint or circulation problems. Patients can also find attempting to reach maximal effort demanding and uncomfortable. Heart rate recovery (HRR) after maximal exercise has been shown to indicate post-operative risk of complications, and is also related to life-expectancy in people with heart failure. The utility of HRR after submaximal exercise however has not been investigated as extensively. One group demonstrated that submaximal HRR predicts post-operative complications after lung surgery, and submaximal HRR also predicts life-expectancy in healthy individuals. There is less information about submaximal HRR as the methods of measuring it are not standardised. Previous work by our group has confirmed the reproducibility of submaximal HRR in a healthy population, and demonstrated different ways in which to measure it. The investigators believe that submaximal HRR provides a middle-ground method of assessing how fit a patient is for surgery. With informed consent, 95 patients across four hospitals in the West of Scotland will perform a step test pre-operatively. The step test will involve non-invasive measurement of the heart rate. Patients will exercise until approximately two-thirds of their predicted maximum heart rate is reached and then recover sitting, whilst the rate of their heart rate recovery is recorded. Patients will have pre- and post-operative troponin values measured (blood marker of strain/injury to the heart). Alongside the blood tests, patients will also answer questionnaires related to their quality of life, and information regarding other post-operative complications will be recorded. The study aims to demonstrate that submaximal HRR is predictive of post-operative myocardial injury (stress/injury to the heart wall due to the body's response to the operation) and that is it a valid measure when compared to the scores, blood tests and exercise tests that are currently in use in the NHS. In the future, submaximal exercise testing with HRR measurement may be offered to patients unable to perform CPET and will guide shared decision-making between patient, surgeon and anaesthetist to ensure the best outcome for the patient regarding their surgical options.

Interventions

None listed

Sponsors

NHS National Waiting Times Centre Board
CollaboratorOTHER
NHS Greater Glasgow and Clyde
CollaboratorOTHER
NHS Ayrshire and Arran
CollaboratorOTHER
NHS Lanarkshire
CollaboratorOTHER_GOV
University of Glasgow
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Provision of informed consent * Age 50 years or over * Able to walk unaided * Planned elective intermediate/high risk surgery as defined by the ESC/ESA guidelines (i.e. \>1% risk of mortality)

Exclusion criteria

* Pregnancy * Ongoing participation in any investigational research which could undermine the scientific basis of the study * Presence of any of the American Thoracic Society's contraindications to exercise testing * Previous intermediate/high risk surgery within three months prior to recruitment * Previous participation in the VERVE study at any time

Design outcomes

Primary

MeasureTime frameDescription
Post-operative myocardial injury48 hours post-operativelyPost-operative troponin over the 99th centile upper reference limit plus a 20% change (increase or decrease)

Secondary

MeasureTime frameDescription
Major adverse kidney events30 days post-operativelyComposite of renal mortality, renal replacement therapy, over 30% decline in eGFR from baseline
Cardiovascular complications7 days post-operativelyIncidence of myocardial infarction, cardiac death, non-fatal cardiac arrest, coronary revascularisation, pulmonary embolus, deep-veined thrombosis, or new onset atrial fibrillation
Major adverse cardiac events30 days post-operativelyComposite of cardiac death, myocardial infarction, non-fatal cardiac arrest, and coronary revascularisation
Infective complications7 days post-operativelyPresence of fever \<38.5 and clinical suspicion of infection
Neurological complications7 days post-operativelyDelirium or stroke
Pulmonary complications7 days post-operativelyAtelectasis, pneumonia, acute respiratory distress syndrome or pulmonary aspiration
Acute Kidney Injury1 week post-operativelyAs defined by KDIGO consensus
EQ-5D-5L30 days and 1 year post-operativelyPatient reported quality of life score
Days alive and out of hospital30 days post-operatively
Length of hospital stay (with/without hospital mortality)Up to 1 year post-operatively
Readmission to hospitalWithin 30 days post-operatively
Admission/re-admission to Intensive Care14 days post-operatively
MortalityDay 30, day 90 and 1 year post-operatively
Quality of recovery scale - 152 days post-operatively

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026